You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-GSK3 beta antibody [G8]See all GSK3 beta primary antibodies ...
  • Description
    Mouse monoclonal [G8] to GSK3 beta
  • SpecificityThis antibody is specific for GSK3 beta
  • Tested applicationsWB, IP, ELISA, ICC/IF more details
  • Species reactivity
    Reacts with: Rat, Human, Xenopus laevis
  • Immunogen

    E.coli produced recombinant Xenopus laevis GSK3 beta.

  • EpitopeThe exact epitope recognised by this antibody has not been mapped.

Applications

Our Abpromise guarantee covers the use of ab2602 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/1000. Predicted molecular weight: 52 kDa.
IP IP: Use at an assay dependent dilution.
Use at a concentration of 5 - 10 µg. The protein does not retain the kinase activity after immunoprecipitation.
ELISA ELISA: 1/1000.
ICC/IF ICC/IF: Use at an assay dependent dilution. PubMed: 19047045

Target

  • FunctionParticipates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Phosphorylates MACF1 and this phosphorylation inhibits the binding of MACF1 to microtubules which is critical for its role in bulge stem cell migration and skin wound repair.
  • Tissue specificityExpressed in testis, thymus, prostate and ovary and weakly expressed in lung, brain and kidney.
  • Sequence similaritiesBelongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. GSK-3 subfamily.
    Contains 1 protein kinase domain.
  • Post-translational
    modifications
    Phosphorylated by AKT1 and ILK1. Activated by phosphorylation at Tyr-216.
  • Cellular localizationCytoplasm. Nucleus. Cell membrane. The phosphorylated form shows localization to cytoplasm and cell membrane. The MEMO1-RHOA-DIAPH1 signaling pathway controls localization of the phosophorylated form to the cell membrane.
  • Target information above from: UniProt accession P49841 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Glycogen Synthase Kinase 3 Beta antibodyGlycogen synthase kinase-3 beta antibodyGSK 3 beta antibody
      GSK 3B antibodyGSK-3 beta antibodyGSK3B antibodyGSK3B protein antibodyGSK3B_HUMAN antibodyGSK3beta isoform antibodySerine/threonine-protein kinase GSK3B antibody
    see all

Anti-GSK3 beta antibody [G8] images

  • ab2602 staining GSK3 beta in primary chondrocytes from the Sox9c/c mice after Cre-adenovirus infection by Immunocytochemistry/ Immunofluorescence.

References for Anti-GSK3 beta antibody [G8] (ab2602)

This product has been referenced in:
  • Topol L  et al. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 284:3323-33 (2009). WB, ICC/IF . Read more (PubMed: 19047045) »
  • Saxena C  et al. An immuno-chemo-proteomics method for drug target deconvolution. J Proteome Res 7:3490-7 (2008). WB ; Human . Read more (PubMed: 18590316) »

See all 3 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Western blot
Sample Human Cell lysate - whole cell (A549)
Loading amount 20 µg
Specification A549
Treatment TRAIL
Gel Running Conditions Reduced Denaturing (12.5% SDS-PAGE)
Blocking step Odyssey as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 100% · Temperature: 20°C
Username

Verified customer

Submitted Apr 02 2012

Application Western blot
Sample Human Cell lysate - whole cell (293FT)
Loading amount 40 µg
Specification 293FT
Gel Running Conditions Reduced Denaturing (10%)
Blocking step Milk as blocking agent for 16 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 4°C
Username

Verified customer

Submitted Sep 11 2009

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"